These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. MicroRNAs: small but potent oncogenes or tumor suppressors. Lee YS; Dutta A Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027 [TBL] [Abstract][Full Text] [Related]
8. [Combinatorial RNAi and its application in cancer gene therapy]. Fei LN; Wang QZ; Xu RA Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998 [TBL] [Abstract][Full Text] [Related]
9. RNA interference for the treatment of cancer. Putral LN; Gu W; McMillan NA Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967 [TBL] [Abstract][Full Text] [Related]
10. The microRNA pathway and cancer. Kwak PB; Iwasaki S; Tomari Y Cancer Sci; 2010 Nov; 101(11):2309-15. PubMed ID: 20726859 [TBL] [Abstract][Full Text] [Related]
11. Short interfering RNAs as a tool for cancer gene therapy. Izquierdo M Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA and cancer: Current status and prospective. Wu W; Sun M; Zou GM; Chen J Int J Cancer; 2007 Mar; 120(5):953-60. PubMed ID: 17163415 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-based therapeutics for cancer. Wang V; Wu W BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188 [TBL] [Abstract][Full Text] [Related]
14. microRNAs: Master regulators as potential therapeutics in cancer. Garofalo M; Croce CM Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797 [TBL] [Abstract][Full Text] [Related]
15. RNAi therapeutics and applications of microRNAs in cancer treatment. Uchino K; Ochiya T; Takeshita F Jpn J Clin Oncol; 2013 Jun; 43(6):596-607. PubMed ID: 23592885 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and other small silencing RNAs in cancer. Rovira C; Güida MC; Cayota A IUBMB Life; 2010 Dec; 62(12):859-68. PubMed ID: 21154820 [TBL] [Abstract][Full Text] [Related]
17. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Spizzo R; Rushworth D; Guerrero M; Calin GA Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859 [TBL] [Abstract][Full Text] [Related]
18. miR-214: a potential biomarker and therapeutic for different cancers. Sharma T; Hamilton R; Mandal CC Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843 [TBL] [Abstract][Full Text] [Related]
19. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Dykxhoorn DM; Lieberman J Annu Rev Med; 2005; 56():401-23. PubMed ID: 15660519 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. Cui SY; Wang R; Chen LB J Cell Mol Med; 2014 Oct; 18(10):1913-26. PubMed ID: 25124875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]